SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
FENC

Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · USD
Healthcare · Biotechnology
$13.09-$0.36 (-2.68%)
 
Market cap
$462M
Insider Score
Analyst consensus
Market Cap$462.14M+67.0%
Revenue (ttm)$66.37M
Net Income$2.03M
EPS$0.03
Shares Out35.31M
PE Ratio436.33
Forward PE12.47
Dividendn/a
Ex-Dividend Daten/a
Volume398,144
Open$13.15
Previous Close$13.45
Day's Range$12.64 - $13.55
52-Week Range$5.65 - $13.85
Beta1.21
AnalystsStrong Buy
Price Target$17.60(+34.45%)
Earnings DateNov 12, 2026
-2.68% (1D)
No price history available.

About FENC

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Address
68 TW Alexander Drive, Research Triangle Park, NC, 27709, United States
Market Cap
462 million
Employees
35
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$667.22K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $19.00 (+45.1%)

1 firm rating FENC in the last 3 months, one vote each. Issuer-paid research is not counted.

1 Day
-2.68%
5 Days
+12.65%
1 Month
+26.84%
6 Months
+31.82%
1 Year
+66.96%

$FENC stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in FENC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by FENC's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

FENC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New FENC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to FENC from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from FENC’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Analyst PT increase and Buy rating, Q3 earnings beat, record revenue reported, and positive analyst sentiment on upside potential.

Recent Insider Activity

Buys
0
Sells
4
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-46.0 since Aug 21
0255075100Aug 21 — Insider Score 46.0Aug 22 — Insider Score 46.0Aug 23 — Insider Score 46.0Aug 24 — Insider Score 46.0Aug 25 — Insider Score 46.0Aug 26 — Insider Score 45.0Aug 27 — Insider Score 45.0Aug 28 — Insider Score 45.0Aug 29 — Insider Score 35.0Aug 30 — Insider Score 35.0Aug 31 — Insider Score 35.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 21.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.21%
IWCiShares Micro-Cap ETF0.08%

Weight is the stock’s share of each fund’s holdings.